CASE DISCUSSION
Management of Progressive Pulmonary Fibrosis
Presented from India by Dr. Deepak Muthreja0
Likes
2483
Views
99
Shares
99
Bookmarks
0
Credit Points
0
Learning Hours
0
CPD/CME Points
0
Courses Completed
Case Description
Pulmonary fibrosis is diagnosed through a combination of medical history, imaging studies (like high-resolution CT scans), pulmonary function tests, and sometimes lung biopsies. Treatment often involves medications such as corticosteroids, immunosuppressants (like azathioprine or mycophenolate),...
Case Summary
- Dr. Subna discusses progressive pulmonary fibrosis (PPF), highlighting its increasing prevalence post-COVID and the challenges in determining which patients require treatment versus observation. The talk will cover the definition, management, and crucial considerations for these patients, especially given the significant advancements in interstitial lung disease (ILD) treatment over the last decade.
Speaker Profile
Dr. Deepak Muthreja
Alumni- P. D. U Medical CollegeHead of Department Pulmonary Medicine, American Oncology Institute, Nagpur
Disclosures
Assimilate requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships for anyone with the ability to control the content of this educational activity have been reviewed and mitigated. Others involved in the planning of this activity have no relevant financial relationships.